Skip to main content
ConductScienceScienceDex

Benjamin L Wolozin

NIH Rank #1416
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2421162Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Anatomy & Cell Biology
  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$3.1M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#1,416
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Benjamin L Wolozin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Benjamin L Wolozin as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG095773-02R01
    tRNA Epitranscriptome and Translational Dysfunction in ADRD
    Boston University
    $801.6K
    award amount
  • 5U01AG082665-03U01
    APOE Genotype Mediated Effects on Alzheimer Disease Risk and Mechanisms
    Boston University
    $795.4K
    award amount
  • 5R01AG096052-02R01
    tRNA modifications regulating mitochondrial function and the mitochondrial proteome in AD/ADRD
    Boston University
    $750.8K
    award amount
  • 5R01AG080810-04R01
    The role of N6-methyladenosine modified RNA in Alzheimer's disease
    Boston University
    $736.7K
    award amount

Award organization

Organizations that administered FY2026 awards listing Benjamin L Wolozin as a PI.

FY2026 award administered by Boston University (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Boston University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1917
  6. 2024
    Entered Top 25% Nationally
    Ranked #1917
  7. 2024
    Entered Top 10% Nationally
    Ranked #1917
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Entered Top 5% Nationally
    Ranked #972
  10. 2025
    R01 Grant Holder
  11. 2025
    Program/Center Grant Leader
  12. 2026
    $10M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Benjamin L Wolozin.

Xiaoling Zhang
Boston University
8
shared awards
Peter C Dedon
Boston University
4
shared awards
Glenn Larsen
Aquinnah Pharmaceuticals, Inc.
3
shared awards
Gyungah Jun
Boston University
3
shared awards
Lindsay A. Farrer
Boston University
3
shared awards

Explore further

Find collaborators for Benjamin L Wolozin

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Benjamin L Wolozin | NIH Award Records | ConductScience